Chemical identity
2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline dihydrochloride
CAS not listed · C41H49Cl2N5O2S2
01Identity
Identifiers and names for this exact compound. Empty fields are left unassigned.
| Lazychem ID | LC-08593 |
|---|---|
| PubChem CID | 175673582 |
| Name | 2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline dihydrochloride |
| CAS RN | Not listed |
| Molecular formula | C41H49Cl2N5O2S2 |
| Molecular weight | 778.90 g/mol |
| IUPAC name | 2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline dihydrochloride |
| InChIKey | BVYAIJBWFRTFPL-UHFFFAOYSA-N |
02Structure identifiers
![2D structure: 2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline dihydrochloride](/structures/pubchem/175673582/no-cas-2-7-bis-4-4-benzo-b-thiophen-4-yl-piperazin-1-yl-butoxy-quinoline-dihydrochloride-2d-structure-900.png)
Structure facts for this exact identity.
| Molecular formula | C41H49Cl2N5O2S2 |
|---|---|
| InChIKey | BVYAIJBWFRTFPL-UHFFFAOYSA-N |
| Ring count | 8 |
| Defined stereocentres | 0 |
| Unassigned stereocentres | 0 |
| SMILES | N1(C2=C(C=CS3)C3=CC=C2)CCN(CCCCOC4=CC5=C(C=CC(OCCCCN6CCN(C7=C(C=CS8)C8=CC=C7)CC6)=N5)C=C4)CC1.Cl.Cl |
|---|---|
| InChI | InChI=1S/C41H47N5O2S2.2ClH/c1(17-43-19-23-45(24-20-43)37-7-5-9-39-34(37)15-29-49-39)3-27-47-33-13-11-32-12-14-41(42-36(32)31-33)48-28-4-2-18-44-21-25-46(26-22-44)38-8-6-10-40-35(38)16-30-50-40;;/h5-16,29-31H,1-4,17-28H2;2*1H |
03India status for this compound
These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.
| NDPS / RCS | NOT FOUND IN REVIEWED ENTRIES | No CAS number is available for an exact comparison. Generic and analogue entries were not evaluated. |
|---|---|---|
| SCOMET | NOT FOUND IN REVIEWED CAS ENTRIES | No CAS number is available for an exact comparison. Generic and analogue entries were not evaluated. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · source version 1985-09-16
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · source version 2026-03-11
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · source version 2024-09-02
04Names and relationships
Associated parent compound
Brexpiprazole
View API and impurity familyOther names
- Brexpiprazole Impurity 30 (DiHCl Salt)
05Documented history
Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.
No verified discovery, first report, occurrence, use or issue event is currently available for this identity.
06Sources
- S01PubChem compound record, CID 175673582
Names and machine-readable chemical identity properties.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. This page does not reproduce vendor descriptions or contributed narrative text.
- S03Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S04Controlled-substances notifications and amendments
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S05Appendix 3, SCOMET List
Directorate General of Foreign Trade, Government of India. Used for the exact-compound India status shown on this page.
